These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
330 related items for PubMed ID: 22491657
21. Safety and efficacy of long-acting somatostatin treatment in autosomal-dominant polycystic kidney disease. Ruggenenti P, Remuzzi A, Ondei P, Fasolini G, Antiga L, Ene-Iordache B, Remuzzi G, Epstein FH. Kidney Int; 2005 Jul; 68(1):206-16. PubMed ID: 15954910 [Abstract] [Full Text] [Related]
22. Massive renal size is not a contraindication to a laparoscopic approach for bilateral native nephrectomies in autosomal dominant polycystic kidney disease (ADPKD). Wisenbaugh ES, Tyson MD, Castle EP, Humphreys MR, Andrews PE. BJU Int; 2015 May; 115(5):796-801. PubMed ID: 24903738 [Abstract] [Full Text] [Related]
23. Sirolimus reduces polycystic liver volume in ADPKD patients. Qian Q, Du H, King BF, Kumar S, Dean PG, Cosio FG, Torres VE. J Am Soc Nephrol; 2008 Mar; 19(3):631-8. PubMed ID: 18199797 [Abstract] [Full Text] [Related]
24. Total kidney and liver volume is a major risk factor for malnutrition in ambulatory patients with autosomal dominant polycystic kidney disease. Ryu H, Kim H, Park HC, Kim H, Cho EJ, Lee KB, Chung W, Oh KH, Cho JY, Hwang YH, Ahn C. BMC Nephrol; 2017 Jan 14; 18(1):22. PubMed ID: 28088190 [Abstract] [Full Text] [Related]
26. Autosomal dominant polycystic kidney disease: risk factor for nonmelanoma skin cancer following kidney transplantation. Bretagnol A, Halimi JM, Roland M, Barbet C, Machet L, Al Najjar A, Marlière JF, Badin J, Nivet H, Lebranchu Y, Büchler M. Transpl Int; 2010 Sep 14; 23(9):878-86. PubMed ID: 20230542 [Abstract] [Full Text] [Related]
27. Outcome of kidney transplantation in patients with polycystic kidney disease: a single center study. Roozbeh J, Razmkon AR, Jalaeian H, Raiss-Jalali GA, Behzadi S, Sagheb MM, Salahi H, Bahador A, Nikeghbalian S, Davari HR, Salehipour M, Malek-Hosseini SA. Saudi J Kidney Dis Transpl; 2008 Jan 14; 19(1):72-5. PubMed ID: 18087127 [Abstract] [Full Text] [Related]
28. Bilateral laparoscopic nephrectomy for significantly enlarged polycystic kidneys: a technique to optimize outcome in the largest of specimens. Desai PJ, Castle EP, Daley SM, Swanson SK, Ferrigni RG, Humphreys MR, Andrews PE. BJU Int; 2008 Apr 14; 101(8):1019-23. PubMed ID: 18190626 [Abstract] [Full Text] [Related]
29. [Renal transplantation in Autosomal Dominant Polycystic Kidney Disease (ADPKD)]. Perico N, Cortinovis M, Remuzzi G. G Ital Nefrol; 2016 Apr 14; 33(5):. PubMed ID: 27796021 [Abstract] [Full Text] [Related]
30. Case report: bilateral hand-assisted laparoscopic nephrectomy in a patient with polycystic horseshoe kidney. Hammontree LN, Passman CM. J Endourol; 2006 Jun 14; 20(6):397-8. PubMed ID: 16808650 [Abstract] [Full Text] [Related]
31. Comparison of MRI segmentation techniques for measuring liver cyst volumes in autosomal dominant polycystic kidney disease. Farooq Z, Behzadi AH, Blumenfeld JD, Zhao Y, Prince MR. Clin Imaging; 2018 Jun 14; 47():41-46. PubMed ID: 28846875 [Abstract] [Full Text] [Related]
32. Kidney transplant patient with immunoglobulin A nephropathy subsequently diagnosed as concurrent autosomal dominant polycystic kidney disease during 17-year follow-up. Usui J, Kai H, Kaneko S, Takahashi-Kobayashi M, Hagiwara M, Takahashi K, Oda T, Yamagata K. CEN Case Rep; 2020 May 14; 9(2):106-108. PubMed ID: 31792758 [Abstract] [Full Text] [Related]
33. [Autosomal dominant polycystic kidney disease. Case report of a 20 kg polycystic kidney]. Leippold T, Pestalozzi D, Gloor HJ, Fehr JL. Urologe A; 2001 Jan 14; 40(1):42-5. PubMed ID: 11225431 [Abstract] [Full Text] [Related]
34. Lanreotide Reduces Liver Growth In Patients With Autosomal Dominant Polycystic Liver and Kidney Disease. van Aerts RMM, Kievit W, D'Agnolo HMA, Blijdorp CJ, Casteleijn NF, Dekker SEI, de Fijter JW, van Gastel M, Gevers TJ, van de Laarschot LFM, Lantinga MA, Losekoot M, Meijer E, Messchendorp AL, Neijenhuis MK, Pena MJ, Peters DJM, Salih M, Soonawala D, Spithoven EM, Visser FW, Wetzels JF, Zietse R, Gansevoort RT, Drenth JPH, DIPAK-1 Investigators. Gastroenterology; 2019 Aug 14; 157(2):481-491.e7. PubMed ID: 31022403 [Abstract] [Full Text] [Related]
35. Autosomal Dominant Polycystic Kidney Disease Transplant Recipients After Kidney Transplantation: A Single-center Experience. Illesy L, Kovács DÁ, Szabó RP, Asztalos L, Nemes B. Transplant Proc; 2017 Sep 14; 49(7):1522-1525. PubMed ID: 28838432 [Abstract] [Full Text] [Related]
36. [Active uremia therapy in autosomal dominant polycystic kidney disease]. Katre S, Leivestad T, Fauchald P. Tidsskr Nor Laegeforen; 2000 Mar 30; 120(9):1015-9. PubMed ID: 10833958 [Abstract] [Full Text] [Related]
37. Graft Survival in Patients With Polycystic Kidney Disease With Nephrectomy of Native Kidney Pretransplant. García-Rubio JH, Carrasco Valiente J, Campos Hernández JP, Ruiz García J, Márquez López J, Regueiro López JC, Cano Castiñeira R, Pendón Ruiz de Mier MV, Requena Tapia MJ. Transplant Proc; 2015 Nov 30; 47(9):2615-7. PubMed ID: 26680051 [Abstract] [Full Text] [Related]
38. Simultaneous Native Nephrectomy and Kidney Transplantation in Patients With Autosomal Dominant Polycystic Kidney Disease. Veroux M, Zerbo D, Basile G, Gozzo C, Sinagra N, Giaquinta A, Sanfiorenzo A, Veroux P. PLoS One; 2016 Nov 30; 11(6):e0155481. PubMed ID: 27257690 [Abstract] [Full Text] [Related]
39. Simultaneous bilateral native nephrectomy and living donor renal transplantation are successful for polycystic kidney disease: the University of Maryland experience. Kramer A, Sausville J, Haririan A, Bartlett S, Cooper M, Phelan M. J Urol; 2009 Feb 30; 181(2):724-8. PubMed ID: 19091353 [Abstract] [Full Text] [Related]